Healthcare provider profile · identity verified

Kareem Hamad, MD

Family Practice · UTICA, NY · NPI 1932427127

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	456	55
Levothyroxine Sodium	Levothyroxine Sodium	369	60
Gabapentin	Gabapentin	337	58
Atorvastatin Calcium	Atorvastatin Calcium	311	75
Furosemide	Furosemide	296	64
Pantoprazole Sodium	Pantoprazole Sodium	288	70
Potassium Chloride	Potassium Chloride	278	37
Sertraline Hcl	Sertraline Hcl	196	35
Amlodipine Besylate	Amlodipine Besylate	191	53
Tamsulosin Hcl	Tamsulosin Hcl	153	32
Xarelto	Rivaroxaban	153	21
Losartan Potassium	Losartan Potassium	142	29
Mirtazapine	Mirtazapine	139	39
Carvedilol	Carvedilol	134	22
Duloxetine Hcl	Duloxetine Hcl	132	28
Metoprolol Succinate	Metoprolol Succinate	126	35
Lisinopril	Lisinopril	125	38
Buspirone Hcl	Buspirone Hcl	123	21
Metoprolol Tartrate	Metoprolol Tartrate	123	32
Clopidogrel	Clopidogrel Bisulfate	116	28
Escitalopram Oxalate	Escitalopram Oxalate	112	22
Metformin Hcl	Metformin Hcl	110	24
Famotidine	Famotidine	109	22
Rosuvastatin Calcium	Rosuvastatin Calcium	104	18
Levetiracetam	Levetiracetam	102	15
Memantine Hcl	Memantine Hcl	90	17
Donepezil Hcl	Donepezil Hcl	87	16
Fluoxetine Hcl	Fluoxetine Hcl	85	11
Trazodone Hcl	Trazodone Hcl	84	22
Divalproex Sodium	Divalproex Sodium	83	18
Ranolazine Er	Ranolazine	82	suppressed
Rexulti	Brexpiprazole	82	suppressed
Torsemide	Torsemide	81	17
Diclofenac Sodium	Diclofenac Sodium	80	17
Prednisone	Prednisone	79	49
Allopurinol	Allopurinol	76	suppressed
Simvastatin	Simvastatin	74	12
Sucralfate	Sucralfate	73	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	72	suppressed
Midodrine Hcl	Midodrine Hcl	71	20
Bisoprolol Fumarate	Bisoprolol Fumarate	70	16
Januvia	Sitagliptin Phosphate	63	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	59	11
Scopolamine	Scopolamine	57	suppressed
Finasteride	Finasteride	53	13
Spironolactone	Spironolactone	52	14
Hydralazine Hcl	Hydralazine Hcl	49	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	48	47
Baclofen	Baclofen	47	suppressed
Risperidone	Risperidone	46	suppressed
Citalopram Hbr	Citalopram Hydrobromide	45	suppressed
Entresto	Sacubitril/Valsartan	45	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	45	21
Topiramate	Topiramate	45	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Trulicity	Dulaglutide	43	12
Lantus	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Nuplazid	Pimavanserin Tartrate	41	suppressed
Nyamyc	Nystatin	39	16
Olanzapine	Olanzapine	39	suppressed
Budesonide	Budesonide	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	suppressed
Cephalexin	Cephalexin	37	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	11
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Jardiance	Empagliflozin	35	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	33	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	32	14
Lactulose	Lactulose	32	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	31	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Memantine Hcl Er	Memantine Hcl	30	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Levofloxacin	Levofloxacin	28	27
Spiriva Handihaler	Tiotropium Bromide	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Atenolol	Atenolol	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Trintellix	Vortioxetine Hydrobromide	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Acetylcysteine	Acetylcysteine	24	suppressed
Azithromycin	Azithromycin	24	11
Omeprazole	Omeprazole	24	11
Farxiga	Dapagliflozin Propanediol	23	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Novolog	Insulin Aspart	23	suppressed
Xifaxan	Rifaximin	23	suppressed
Zenpep	Lipase/Protease/Amylase	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Digoxin	Digoxin	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	20
Nuedexta	Dextromethorphan Hbr/Quinidine	21	suppressed
Rivastigmine	Rivastigmine Tartrate	21	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	20	suppressed
Ingrezza	Valbenazine Tosylate	20	suppressed
Lidocaine Hcl	Lidocaine Hcl	20	11
Metformin Hcl Er	Metformin Hcl	20	suppressed
Misoprostol	Misoprostol	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	19	12
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Lubiprostone	Lubiprostone	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	18	suppressed
Humalog	Insulin Lispro	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Atropine Sulfate	Atropine Sulfate	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Linzess	Linaclotide	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Rivastigmine	Rivastigmine	17	suppressed
Sodium Chloride	0.9 % Sodium Chloride	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Insulin Lispro	Insulin Lispro	16	suppressed
Levemir	Insulin Detemir	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Ramipril	Ramipril	16	suppressed
Budesonide Er	Budesonide	15	suppressed
Calcitriol	Calcitriol	15	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	15	suppressed
Movantik	Naloxegol Oxalate	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Riluzole	Riluzole	15	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	15	suppressed
Trimethoprim	Trimethoprim	15	suppressed
Cilostazol	Cilostazol	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Lamotrigine	Lamotrigine	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Soaanz	Torsemide	14	suppressed
Ajovy Autoinjector	Fremanezumab-Vfrm	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Primidone	Primidone	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Brilinta	Ticagrelor	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Dexamethasone	Dexamethasone	12	12
Nystatin	Nystatin	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Clozapine	Clozapine	11	suppressed
Glatiramer Acetate	Glatiramer Acetate	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Trandolapril	Trandolapril	11	suppressed
Ursodiol	Ursodiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error